close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.5438 -0.0572 (-9.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Third Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
Innovative solutions for academic, CRO, pharma and biotech customers 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
From Harvard Bioscience, Inc.; Etisense
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Second Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
Has served in interim role since January 2023 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces First Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
Designed to meet the pre-clinical testing needs of CROs, pharma and research laboratories 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces CFO Transition
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Third Quarter 2022 Financial Results
“Fighting through challenging times while building the company and new technologies for the future.” 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today